Intravitreal injection ranibizumab

DRUG2 trials

Sponsors

University Hospital, Bonn

Conditions

Choroidal NeovascularizationType 2 Idiopathic Macular Telangiectasia

Phase 2

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

CompletedNCT00504400

University Hospital, BonnType 2 Idiopathic Macular Telangiectasia

Start: 2007-08-31End: 2009-09-30Updated: 2009-09-22

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

CompletedNCT00510965

University Hospital, BonnChoroidal Neovascularization

Start: 2007-08-31End: 2010-04-30Updated: 2012-06-15